You have 9 free searches left this month | for more free features.

MEDI0382

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity Trial in Daytona Beach, Dallas (MEDI0382, Placebo)

Completed
  • Obesity
  • MEDI0382
  • Placebo
  • Daytona Beach, Florida
  • +1 more
Aug 16, 2021

Diabetes, Type II, Obesity Trial in Cambridge (MEDI0382, Placebo)

Completed
  • Diabetes Mellitus, Type II
  • Obesity
  • MEDI0382
  • Placebo
  • Cambridge, United Kingdom
    Research Site
Feb 11, 2021

Type 2 Diabetes, Chronic Kidney Diseases Trial in Worldwide (Cotadutide 100 micrograms, Cotadutide 300 micrograms, Cotadutide

Completed
  • Type 2 Diabetes Mellitus
  • Chronic Kidney Diseases
  • Cotadutide 100 micrograms
  • +4 more
  • Box Hill, Australia
  • +64 more
Mar 28, 2022

Type 2 Diabetes Trial in Neuss (MEDI0382, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • MEDI0382
  • Placebo
  • Neuss, Germany
    Research Site
May 20, 2020

Type II Diabetes, Renal Insufficiency Trial in Germany, United Kingdom (MEDI0382, Placebo)

Completed
  • Type II Diabetes Mellitus
  • Renal Insufficiency
  • MEDI0382
  • Placebo
  • Berlin, Germany
  • +6 more
Apr 10, 2020

Type 2 Diabetes Trial in Chuo-ku, Shinjuku-ku, Suita-shi (MEDI0382 100 µg, MEDI0382 200 µg, MEDI0382 300 µg)

Completed
  • Type 2 Diabetes
  • MEDI0382 100 μg
  • +5 more
  • Chuo-ku, Japan
  • +4 more
Dec 5, 2019

Type 2 Diabetes Trial in Germany, Hungary, United Kingdom (MEDI0382, Placebo, Dapaglifozin)

Completed
  • Type 2 Diabetes Mellitus
  • MEDI0382
  • +3 more
  • Magdeburg, Germany
  • +7 more
Jan 7, 2020

Type 2 Diabetes Trial in Germany (MEDI0382, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • MEDI0382
  • Placebo
  • Berlin, Germany
  • +4 more
Nov 18, 2019

Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)

Completed
  • Diabetes Mellitus, Type 2
  • MEDI0382 low dose
  • +4 more
  • Birmingham, Alabama
  • +118 more
Jul 31, 2020

Safety, Healthy Subjects Trial in Anaheim (MEDI0382, Placebo)

Completed
  • Safety
  • Healthy Subjects
  • MEDI0382
  • Placebo
  • Anaheim, California
    Research Site
Apr 12, 2019

Type 2 Diabetes Trial in Germany (MEDI0382, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • MEDI0382
  • Placebo
  • Berlin, Germany
  • +10 more
Jan 8, 2019

Healthy Volunteers Trial in Daytona Beach (MEDI0382, Warfarin, Esmolol)

Completed
  • Healthy Volunteers
  • MEDI0382
  • +2 more
  • Daytona Beach, Florida
    Research Site
Apr 24, 2018

Renal Insufficiency Trial in Germany, New Zealand (MEDI0382)

Completed
  • Renal Insufficiency
  • MEDI0382
  • Kiel, Germany
  • +3 more
Apr 30, 2018

Diabetes Trial in Guangzhou, Nanjing (Experimental: Cotadutide, Placebo)

Recruiting
  • Diabetes
  • Experimental: Cotadutide
  • Placebo
  • Guangzhou, China
  • +1 more
Jul 21, 2022

Type 2 Diabetes Trial in Shinjuku-ku, Suita-shi (Placebo, Cotadutide)

Completed
  • Type 2 Diabetes
  • Shinjuku-ku, Japan
  • +2 more
Jul 30, 2020

Type 2 Diabetes Trial in Dallas (MEDI0382 Formulation 2, MEDI0382 Formulation 3)

Completed
  • Type 2 Diabetes Mellitus
  • MEDI0382 Formulation 2
  • MEDI0382 Formulation 3
  • Dallas, Texas
    Research Site
Feb 13, 2018

Diabetic Nephropathies Trial in Worldwide (PF-00489791, Placebo)

Completed
  • Diabetic Nephropathies
  • Huntsville, Alabama
  • +159 more
Feb 18, 2019

Healthy Volunteers Trial in Berlin (MEDI0382, Placebo)

Completed
  • Healthy Volunteers
  • MEDI0382
  • Placebo
  • Berlin, Germany
    Research Site
Sep 8, 2015

Healthy Subjects Trial in London (MEDI8111, Placebo)

Completed
  • Healthy Subjects
  • London, United Kingdom
    Research Site
Jan 5, 2016